New patent expiration for Organon drug SINGULAIR

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SINGULAIR
Annual Drug Patent Expirations for SINGULAIR

Singulair is a drug marketed by Organon and is included in three NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

SINGULAIR drug price trends.

Drug patent litigation for SINGULAIR.

This drug has twenty-five patent family members in twenty-five countries.

The generic ingredient in SINGULAIR is montelukast sodium. Additional details are available on the montelukast sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top